Latest IQV Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| NYSE:IQV | Investing.com | Initiates Coverage | Buy | - | |
| Zacks Equity Research | Zacks Equity Research | Initiates Coverage | Hold | - | |
| Sridatri Sarkar | Zacks Equity Research | Initiates Coverage | Buy | - | |
| Google Medical - Diagnostics and Research | TipRanks - Google | Reiterates | Buy | $246.00 → $282.00 +36.00 (14.6%) | |
| Anthropic Medical - Diagnostics and Research | TipRanks - Anthropic | Reiterates | Hold | $226.00 → $256.00 +30.00 (13.3%) | |
| DeepSeek Medical - Diagnostics and Research | TipRanks - DeepSeek | Reiterates | Buy | $239.00 → $277.00 +38.00 (15.9%) | |
| OpenAI Medical - Diagnostics and Research | TipRanks - OpenAI | Reiterates | Buy | $238.00 → $276.00 +38.00 (16.0%) | |
| Unknown Analyst | Jefferies | Maintains | Buy | $220.00 → $290.00 +70.00 (31.8%) | |
| Jared Haase | William Blair | Reiterates | Buy | - | |
| UK | Investing.com | Initiates Coverage | Buy | - | |
| Michael Ryskin | BofA Securities | Reiterates | Buy | $245.00 → $280.00 +35.00 (14.3%) | |
| Ryan Halsted | RBC Capital | Reiterates | Buy | $221.00 → $247.00 +26.00 (11.8%) | |
| Ann Hynes | Mizuho | Maintains | Buy | $215.00 → $230.00 +15.00 (7.0%) | |
| Kallum Titchmarsh | Morgan Stanley | Maintains | Hold | $200.00 | |
| Ryan Halsted | RBC Capital | Maintains | Buy | $221.00 | |
| Sridatri Sarkar | Zacks Equity Research | Initiates Coverage | Sell | - | |
| Moumi Mondal | Zacks Equity Research | Initiates Coverage | Hold | - | |
| Sidharth Sahoo | HSBC | Maintains | Buy | $210.00 → $240.00 +30.00 (14.3%) | |
| Eric Coldwell | Baird | Maintains | Buy | $230.00 → $249.00 +19.00 (8.3%) | |
| Jailendra Singh | Truist | Maintains | Buy | - | |
| Luke Sergott | Barclays | Maintains | Buy | $210.00 | |
| Kallum Titchmarsh | Morgan Stanley | Upgrades | Hold | $200.00 → $225.00 +25.00 (12.5%) | |
| Kallum Titchmarsh | Morgan Stanley | Downgrades | Hold | $225.00 → $200.00 -25.00 (-11.1%) |
